After finishing at $121.16 in the prior trading day, Illumina Inc (NASDAQ: ILMN) closed at $117.69, down -2.86%. On the day, 1698207 shares were traded.
Ratios:
Our goal is to gain a better understanding of ILMN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 66.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.38.
On January 04, 2024, TD Cowen Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $144.
Scotiabank Upgraded its Sector Perform to Sector Outperform on December 18, 2023, while the target price for the stock was maintained at $185.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 22 ’24 when Thaysen Jacob bought 7,330 shares for $135.29 per share. The transaction valued at 991,672 led to the insider holds 14,861 shares of the business.
Hoyt Aimee L sold 315 shares of ILMN for $35,545 on Nov 07 ’23. The SVP, Chief People Officer now owns 8,314 shares after completing the transaction at $112.84 per share. On Aug 22 ’23, another insider, TOUSI SUSAN H, who serves as the SVP, Chief Commercial Officer of the company, sold 500 shares for $167.04 each. As a result, the insider received 83,520 and left with 45,524 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.15 while its Price-to-Book (P/B) ratio in mrq is 3.26.
Stock Price History:
Over the past 52 weeks, ILMN has reached a high of $232.23, while it has fallen to a 52-week low of $89.00.
Shares Statistics:
A total of 159.00M shares are outstanding, with a floating share count of 158.11M. Insiders hold about 0.50% of the company’s shares, while institutions hold 90.74% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 15 different market analysts. On average, analysts expect EPS of $0.04 for the current quarter, with a high estimate of $0.25 and a low estimate of -$0.11, while EPS last year was $0.08. The consensus estimate for the next quarter is $0.15, with high estimates of $0.25 and low estimates of $0.
Analysts are recommending an EPS of between $1.38 and $0.43 for the fiscal current year, implying an average EPS of $0.89. EPS for the following year is $2.44, with 19 analysts recommending between $4.53 and $1.05.
Revenue Estimates
14 analysts predict $1.05B in revenue for the current quarter. It ranges from a high estimate of $1.06B to a low estimate of $1.03B. As of the current estimate, Illumina Inc’s year-ago sales were $1.09B, an estimated decrease of -3.20% from the year-ago figure. For the next quarter, 13 analysts are estimating revenue of $1.11B, a decrease of -4.70% less than the figure of -$3.20% in the same quarter last year. There is a high estimate of $1.15B for the next quarter, whereas the lowest estimate is $1.06B.
Based on 19 analysts’ estimates, the company’s revenue will be $4.85B in the next fiscal year. The high estimate is $5.13B and the low estimate is $4.42B. The average revenue growth estimate for next year is up 7.70% from the average revenue estimate for this year.
